Suppr超能文献

采用常规流液相色谱/串联质谱法在人血清中检测纳克每毫升级别的 FGF-21 生物标志物。

FGF-21 biomarker detection at the sub-nanogram per mL level in human serum using normal-flow liquid chromatography/tandem mass spectrometry.

机构信息

Institute of Mass Spectrometry, State Key Laboratory Base of Novel Functional Materials and Preparation Science, School of Materials Science & Chemical Engineering, Ningbo University, Ningbo, Zhejiang, 315211, China.

Faculty of Electrical Engineering and Computer Science, Ningbo University, Ningbo, Zhejiang, 315211, China.

出版信息

Rapid Commun Mass Spectrom. 2020 Jul 30;34(14):e8817. doi: 10.1002/rcm.8817.

Abstract

RATIONALE

Quantitative detection of the FGF-21 biomarker at the sub-nanogram per mL level in human serum has generally been achieved using nanoflow liquid chromatography/tandem mass spectrometry (LC/MS/MS) due to its high sensitivity. However, a nano-LC/MS/MS-based assay can suffer from limited reproducibility and MS signal instability making it challenging to employ it as a robust analytical method for routine clinical applications.

METHODS

To tackle these limitations, parallel reaction monitoring (PRM)-based targeted protein quantification using normal-flow liquid chromatography coupled with high-resolution, accurate mass instrumentation was evaluated as a possible alternative. Different from the conventional selected reaction monitoring (SRM) using triple quadrupole MS, the proposed strategy used high-resolution orbitrap MS coupled with conventional normal-flow liquid chromatography. The primary goal of this assay development effort is to significantly improve the robustness of the LC/MS/MS-based assay while maintaining high sensitivity by the use of high-resolution MS and a large sample loading volume.

RESULTS

The performance of the normal-flow LC/MS/MS assay was evaluated by using it to quantify the FGF-21 protein, a potential biomarker for non-alcoholic fatty liver disease, in serum samples. Multiple replicated PRM sample quantification results demonstrated the excellent reproducibility and operational robustness of the assay. A limit of quantification of less than 0.4 ng/mL for FGF-21 in a complex serum matrix could be achieved by using the heavy-isotope-labeled peptide technique, a result which is comparable with the sensitivity obtained using the nano-LC/SRM MS-based assay.

CONCLUSIONS

The strategy offered an effective alternative to nano-LC/SRM MS for the quantification of protein biomarkers in a complex biomatrix with much improved reproducibility and operational robustness.

摘要

原理

由于其灵敏度高,通常使用纳流液相色谱/串联质谱(LC/MS/MS)来实现人血清中 FGF-21 生物标志物的亚纳克每毫升级别的定量检测。然而,基于纳米 LC/MS/MS 的测定法可能会受到重现性有限和 MS 信号不稳定的影响,使其难以作为常规临床应用的稳健分析方法。

方法

为了解决这些限制,评估了基于平行反应监测(PRM)的靶向蛋白质定量法,该方法使用常规流速液相色谱与高分辨率、精确质量仪器相结合,作为一种可能的替代方法。与使用三重四极杆 MS 的传统选择反应监测(SRM)不同,该策略使用高分辨率轨道阱 MS 与常规常规流速液相色谱相结合。该测定法开发工作的主要目标是通过使用高分辨率 MS 和大样品加载量,显著提高 LC/MS/MS 测定法的稳健性,同时保持高灵敏度。

结果

使用该法测定血清样品中的 FGF-21 蛋白(非酒精性脂肪性肝病的潜在生物标志物),评估了常规流速 LC/MS/MS 测定法的性能。多次重复的 PRM 样品定量结果表明该测定法具有出色的重现性和操作稳健性。通过使用重同位素标记肽技术,在复杂的血清基质中,FGF-21 的定量下限可低于 0.4ng/mL,这一结果与使用纳米 LC/SRM MS 测定法获得的灵敏度相当。

结论

该策略为在复杂生物基质中定量蛋白质生物标志物提供了一种有效的替代方案,与纳米 LC/SRM MS 相比,其重现性和操作稳健性有了很大提高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验